![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Igraine plc | AQSE:KING | Aquis Stock Exchange | Ordinary Share | GB00BM9CKV18 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.275 | 0.25 | 0.30 | 0.275 | 0.275 | 0.275 | 0.00 | 06:59:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMKING Igraine plc AQSE: KING ("Igraine" or the "Company") 13 September 2021 Company's Shares Suspended whilst finalising Audited Results for 31.12.2020 The Company notes that, further to the announcement on 9 September 2021, whereby unaudited preliminary final results were released to 31 December 2020, the Company's shares were suspended today. Upon finalisation and announcement of the audited financial results, the suspension of the Company's shares will be lifted. The last 6 months at Igraine reflect a period of accelerated reinvigoration. This restoration has included the introduction of new Directors, financings raising over £2,000,000 and the adoption of a broader investment strategy that includes the completion of co-investment rights with Globally renowned Excalibur Healthcare. Corporate restructures of this nature require time, attention and a collective effort to rationalise legacy items, to ensure efficient operating functions are in place. To this end, the delay relates mainly to legacy corporate acitivity and the board is pleased with the progress the Company has made since the year end. It is expected that the audited results to 31 December 2020 will be announced prior to the end of September 2021. The Directors of the Company, who have issued this RIS announcement after due and careful enquiry, accept responsibility for its content. Enquiries Company: Martin Walton (Executive Director) Steve Winfield (Executive Director) info@igraineplc.com AQSE Growth Market Corporate Adviser Peterhouse Capital Limited Guy Miller / Mark Anwyl Tel: +44 (0) 207 469 0930 Media inquiries: Ramsay Smith, Media House International ramsay@mediahouse.co.uk: +44 (0) 7788414856 END
(END) Dow Jones Newswires
September 13, 2021 06:46 ET (10:46 GMT)
1 Year Igraine Chart |
1 Month Igraine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions